Danone S.A. Revenue in 2024

Danone S.A. reported $29.7B in revenue for fiscal year 2024. This represents a decline of 0.4% compared to the 2023 figure of $29.8B.

Danone's revenue has been essentially flat for three years — $29.0 billion in 2022, $29.8 billion in 2023, $29.7 billion in 2024 — a pattern that reflects pricing gains offset by volume pressure in mature European dairy markets, where private-label competition has intensified. That flatness, however, obscures meaningful margin improvement: the recurring operating margin rose 39 basis points to 13.0% in FY2024 as productivity gains of 242 basis points more than offset the 173-basis-point reinvestment into advertising. Net income of $2.19 billion on $29.7 billion in revenue is a reasonable outcome, though the $44.65 billion market capitalization implies investors see limited near-term growth acceleration. The Specialized Nutrition segment is the most profitable part of the business — clinical and infant formula products carry better margins than commodity dairy — and growing it faster is the clearest path to multiple expansion. The Argentina hyperinflation accounting is a recurring reminder of emerging-market exposure. The $161 million negative net income impact in FY2024 — up from $108 million the prior year — is real money removed from the bottom line by macroeconomic conditions entirely outside Danone's control. The 2016 WhiteWave acquisition at $12.5 billion was the largest in company history. Five years later, plant-based dairy was growing faster than anyone had projected, and Danone's Alpro and Silk brands were well-positioned. Since then, the category has normalized. The acquisition price looks less obviously justified today than it did in 2019.